Hepatic hemangioma epidemiology and demographics

Hepatic hemangioma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Hepatic Hemangioma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Hepatic hemangioma epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Hepatic hemangioma epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Hepatic hemangioma epidemiology and demographics
CDC on Hepatic hemangioma epidemiology and demographics
Hepatic hemangioma epidemiology and demographics in the news
Blogs on Hepatic hemangioma epidemiology and demographics
Directions to Hospitals Treating Hepatic hemangioma
Risk calculators and risk factors for Hepatic hemangioma epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Epidemiology and Demographics

Incidence

• The incidence ranges from 0.4-20% of the population.

Age

• Hepatic hemangiomas can occur at any time, but are most common in people in their 30s - 50s.

Gender

• Women are affected more often than men (5:1), and usually have bigger tumors than men.